{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:31:58Z","timestamp":1782505918233,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ejogrb.2014.05.013","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T07:22:26Z","timestamp":1401693746000},"page":"46-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?"],"prefix":"10.1016","volume":"179","author":[{"given":"T.","family":"Shavit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ellenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Michaeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kartchovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Ruzov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Shalom-Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2014.05.013_bib0005","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1471-0528.2006.01008.x","article-title":"PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors","volume":"113","author":"Broekmans","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0030-1265669","article-title":"Ovarian hyperstimulation syndrome: definition, incidence, and classification","volume":"28","author":"Zivi","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/humupd\/8.3.291","article-title":"A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0020","first-page":"CD002806","article-title":"Embryo freezing for preventing ovarian hyperstimulation syndrome","volume":"2","author":"D'Angelo","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0015-0282(16)43508-9","article-title":"Ovarian hyperstimulation syndrome: a current survey","volume":"30","author":"Schenker","year":"1978","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10815-010-9387-6","article-title":"Ovarian hyperstimulation syndrome: pathophysiology and prevention","volume":"27","author":"Nastri","year":"2010","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2010.03.028","article-title":"Preventing ovarian hyperstimulation syndrome: guidance for the clinician","volume":"94","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0040","article-title":"In vitro maturation of immature oocytes and IVF\/ICSI in PCOS patients","volume":"104","author":"Cha","year":"2006","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0045","first-page":"665","article-title":"A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries","volume":"100","author":"Child","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0050","first-page":"CD006606","article-title":"In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction","volume":"10","author":"Siristatidis","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejogrb.2012.07.001","article-title":"PCOS patients can benefit from in vitro maturation (IVM) of oocytes","volume":"165","author":"Shalom-Paz","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0060","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5653\/cerm.2012.39.4.166","article-title":"Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: in vitro maturation, GnRH agonist, and GnRH antagonist cycles","volume":"39","author":"Choi","year":"2012","journal-title":"Clin Exp Reprod Med"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0070","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"European Cetrorelix Study Group. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin","volume":"15","author":"Albano","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0075","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.fertnstert.2013.01.148","article-title":"Estrogen-suppressed in vitro maturation: a novel approach to in vitro maturation","volume":"99","author":"Vitek","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0080","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/humrep\/den210","article-title":"A 38h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles","volume":"23","author":"Son","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0085","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1093\/humrep\/dep246","article-title":"GnRHa to trigger final oocyte maturation: a time to reconsider","volume":"24","author":"Humaidan","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0032-1311522","article-title":"In vitro oocyte maturation: current status","volume":"30","author":"Nogueira","year":"2012","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0100","article-title":"In vitro maturation of oocytes: a novel method of treatment of patients with polycystic ovarian syndrome undergoing in vitro fertilization","volume":"150","author":"Ellenbogen","year":"2014","journal-title":"Harefuah"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0105","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2012.06.055","article-title":"Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome","volume":"98","author":"Junk","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/humrep\/der463","article-title":"Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support","volume":"27","author":"Imbar","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0115","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1093\/humrep\/des279","article-title":"Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles","volume":"27","author":"Humaidan","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.rbmo.2011.11.001","article-title":"The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives","volume":"24","author":"Humaidan","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1600-0412.2012.01399.x","article-title":"The gonadotropin-releasing hormone antagonist protocol\u2013the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation","volume":"91","author":"Kol","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0130","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.fertnstert.2012.03.015","article-title":"Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders","volume":"97","author":"Griffin","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0135","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.fertnstert.2014.01.019","article-title":"Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and \u201cfreeze-all\u201d approach in GnRH antagonist protocol","volume":"101","author":"Fatemi","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0140","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/humrep\/det124","article-title":"Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG","volume":"28","author":"Seyhan","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0145","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.fertnstert.2012.06.043","article-title":"Retrieving oocytes from small non-stimulated follicles in polycystic ovary syndrome (PCOS): in vitro maturation (IVM) is not indicated in the new GnRH antagonist era","volume":"98","author":"de Ziegler","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0150","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/humrep\/deh603","article-title":"In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience","volume":"20","author":"Le Du","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1472-6483(10)60511-1","article-title":"In-vitro maturation of human oocytes","volume":"8","author":"Chian","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0160","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1472-6483(10)61101-7","article-title":"In-vitro maturation of immature oocytes for infertile women with PCOS","volume":"8","author":"Chian","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0165","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1093\/humrep\/der220","article-title":"GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study","volume":"26","author":"Kol","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2012.04.046","article-title":"In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case\u2013control study of 194 treatment cycles","volume":"98","author":"Gremeau","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0175","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/del484","article-title":"Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial","volume":"22","author":"Baart","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/REP-09-0187","article-title":"The impact of ovarian stimulation for IVF on the developing embryo","volume":"139","author":"Santos","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0185","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1093\/humrep\/dei195","article-title":"Fertilization, cleavage and blastocyst development according to the maturation timing of oocytes in in vitro maturation cycles","volume":"20","author":"Son","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0190","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.fertnstert.2006.11.027","article-title":"Pregnancies and deliveries after transfer of human blastocysts derived from in vitro matured oocytes in in vitro maturation cycles","volume":"87","author":"Son","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0195","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.AOG.0000284627.38540.80","article-title":"Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection","volume":"110","author":"Buckett","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0200","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.fertnstert.2004.11.044","article-title":"Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer","volume":"83","author":"Cha","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0205","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2013.12.011","article-title":"Comparison of complication rates and pain scores after transvaginal ultrasound-guided oocyte pickup procedures for in vitro maturation and in vitro fertilization cycles","volume":"101","author":"Seyhan","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.05.013_bib0210","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7827-12-18","article-title":"The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVM","volume":"12","author":"Ortega-Hrepich","year":"2014","journal-title":"Reprod Biol Endocrinol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514002887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514002887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:31:24Z","timestamp":1759555884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211514002887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":42,"alternative-id":["S0301211514002887"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.05.013","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}